SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-092566
Filing Date
2023-08-16
Accepted
2023-08-16 16:18:31
Documents
13
Period of Report
2023-08-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2323892d1_8k.htm   iXBRL 8-K 31621
2 EXHIBIT 10.1 tm2323892d1_ex10-1.htm EX-10.1 64262
  Complete submission text file 0001104659-23-092566.txt   283033

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vygr-20230811.xsd EX-101.SCH 3048
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vygr-20230811_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vygr-20230811_pre.xml EX-101.PRE 22381
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2323892d1_8k_htm.xml XML 3210
Mailing Address 64 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 64 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37625 | Film No.: 231178427
SIC: 2836 Biological Products, (No Diagnostic Substances)